MedTrace Logo

Botulinum Toxin Injection in Reducing Scar Following Cheilorrhaphy.

NCT07137234 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2026-02-10

No results posted yet for this study

Summary

the aim of the study will be directed to evaluate clinically the effect of botulinum toxin type A injection on reducing the scar following cleft lip surgical repair.

Conditions

  • Unilateral Cleft Lip

Interventions

PROCEDURE

Modified Millard rotation advancement flap technique

the cleft is repaired by surgical intervention

DRUG

botulinum toxin injection (BTX A) before surgical intervention

the patient will receive Botulinum toxin type A followed by surgical closure of cleft lip

Sponsors & Collaborators

  • Mansoura University

    lead OTHER

Principal Investigators

  • Basel Saeed Shamaa, Master's · Mansoura University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
10 Weeks
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-03-15
Primary Completion
2026-05-31
Completion
2026-05-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07137234 on ClinicalTrials.gov